FDA.reportPublic FDA data

ziftomenib 200 MG Oral Capsule [Komzifti]

RxCUI
2725996
RxNorm name
ziftomenib 200 MG Oral Capsule [Komzifti]
Display name
ziftomenib 200 MG Oral Capsule [Komzifti]
Full name
ziftomenib 200 MG Oral Capsule [Komzifti]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KomziftiZIFTOMENIBKura Oncology, Inc.b650f696-3391-4274-8b55-a5f5e9d047692025-12-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2725996

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b650f696-3391-4274-8b55-a5f5e9d04769komzifti 200 MG Oral Capsule [PSN] · ziftomenib 200 MG Oral Capsule [Komzifti] [SBD] · Komzifti 200 MG Oral Capsule [SY]31These highlights do not include all the information needed to use KOMZIFTI safely and effectively. See full prescribing information for KOMZIFTI. KOMZIFTI TM (ziftomenib) capsules, for oral use Initial U.S. Approval: 202520251209